Andrew Oh

Andrew Oh is an experienced financial and strategic leader in the healthcare sector, currently serving as a Director on the Board of Directors and Chair of the Audit Committee at Syros Pharmaceuticals since September 2022, and as a Senior Partner at Flagship Pioneering since January 2021. Previous roles include Chief Financial Officer and Senior Advisor at Rubius Therapeutics, and co-founding Leerink Pharmaceutical Investments LLC, where Andrew served as Chief Investment Officer and Chief Operating Officer. Notable earlier positions include Portfolio Manager at Fidelity Investments and Senior Pharma Analyst at Leerink Swann. Andrew holds an M.B.A. from Northwestern University and a B.A. in Biology from Washington University in St. Louis.